Interleukin-10 (IL-10) Receptor Agonists:アゴニストのグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014396)
◆英語タイトル:Interleukin-10 (IL-10) Receptor Agonists -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014396
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥140,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Interleukin-10 (IL-10) Receptor Agonists:アゴニストのグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Interleukin-10 (IL-10) Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Interleukin-10 (IL-10) Receptor Agonists. This report provides information on the therapeutic development based on the Interleukin-10 (IL-10) Receptor Agonists dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Interleukin-10 (IL-10) Receptor Agonists
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Interleukin-10 (IL-10) Receptor Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Interleukin-10 (IL-10) Receptor Agonists and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for Interleukin-10 (IL-10) Receptor Agonists
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Interleukin-10 (IL-10) Receptor Agonists pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• Interleukin-10 (IL-10) Receptor Agonists Overview
• Interleukin-10 (IL-10) Receptor Agonists Disease Associated
• Interleukin-10 (IL-10) Receptor Agonists Pipeline Therapeutics
• Interleukin-10 (IL-10) Receptor Agonists Therapeutics under Development by Companies
• Interleukin-10 (IL-10) Receptor Agonists Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Interleukin-10 (IL-10) Receptor Agonists Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Interleukin-10 (IL-10) Receptor Agonists Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Interleukin-10 (IL-10) Receptor Agonists Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Interleukin-10 (IL-10) Receptor Agonists – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Interleukin-10 (IL-10) Receptor Agonists – Discontinued Products
• Interleukin-10 (IL-10) Receptor Agonists – Dormant Products
• Companies Involved in Therapeutics Development for Interleukin-10 (IL-10) Receptor Agonists
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Interleukin-10 (IL-10) Receptor Agonists by Therapy Area, 2014
• Number of Products under Development for Interleukin-10 (IL-10) Receptor Agonists, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Monotherapy Products
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Combination Products
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Route of Administration
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Stage and Route of Administration
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Molecule Type
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Stage and Molecule Type
• Interleukin-10 (IL-10) Receptor Agonists Therapeutics – Discontinued Products
• Interleukin-10 (IL-10) Receptor Agonists Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for Interleukin-10 (IL-10) Receptor Agonists by Therapy Area, 2014
• Number of Products under Development for Interleukin-10 (IL-10) Receptor Agonists, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Monotherapy Products
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Combination Products
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Route of Administration
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Stage and Route of Administration
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Molecule Type
• Interleukin-10 (IL-10) Receptor Agonists Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • DDoS対策の世界市場:DDoS対策‎ソリューション、DDoS対策サービス
    About DDoS prevention A DDoS attack is a malicious attempt to disrupt the normal functioning of a network resource by making it unavailable to its intended users. A DDoS attack is significantly different from a denial-of-service (DoS) attack, since DDoS attacks use many computers and internet connec …
  • 世界のソーナー装置市場2016
    Notes:Production, means the output of Sonar Systems Revenue, means the sales value of Sonar Systems This report studies Sonar Systems in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, …
  • ドミニカ共和国の富裕層市場:資産配分動向
    This report provides the latest asset allocations of Dominican Republic HNWIs across 13 asset classes. The report also includes projections of the volume, wealth and asset allocations of Dominican Republic HNWIs to 2018 and a comprehensive and robust background of the local economy.
  • 発電機の世界市場:ディーゼル発電機、ガス発電機
    This report estimates the generator sales market, in terms of market size and market share. The market has been segmented into type, end-user, power rating, and region. Power backup is one of the principal requirements for various industrial applications such as data centers, infrastructural develop …
  • 世界の不妊症治療薬パイプライン分析
    The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to sca …
  • Niemann-Pick C1-Like 1 (NPC1L1) Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)
    DelveInsight’s,“Niemann-Pick C1-Like 1 (NPC1L1) Inhibitors-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Niemann-P …
  • 光センサーの世界市場2021
    Notes:Production, means the output of Optical Sensor Revenue, means the sales value of Optical Sensor This report studies Optical Sensor in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with Production, price, reven …
  • 中国のヒト狂犬病ワクチン市場動向(2013-2017)
    In recent years, with increasing number of pets and the lack of strict pet management, the incidence trend of rabies in China is not optimistic. According to the survey data provided by Chinese Centers for Disease Control and Prevention (CDC), there were 130 million dogs in China by April 2012, rank …
  • コロンビアのプラスチックシート/プレート/フィルム市場(~2019):市場規模、動向、予測
    The report Plastic Sheet, Plate and Film Market in Colombia to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for plastic sheets, plates and film in Colombia. The research includes historic data from 2008 to …
  • ドイツの無水マレイン酸市場2015-2019
    About The report brings together facts and figures about maleic anhydride market in Germany covering period of 2009-2019. Statistics, experts’ opinions and estimations are given. The report about maleic anhydride market in Germany covers: - manufacturers capacity, production volumes - company profil …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014396 )"Interleukin-10 (IL-10) Receptor Agonists:アゴニストのグローバル市場2014(薬開発、治験動向)" (英文:Interleukin-10 (IL-10) Receptor Agonists -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。